DJO Global and Lima Corporate Expand U.S. Partnership

February 15, 2011

SAN DIEGO, CA  – DJO Global, Inc. ("DJO", "DJO Global" or the "Company"), a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, and Lima Corporate, a European-based orthopedic implants company, announced today that DJO Surgical, a DJO Global business unit, has reached an agreement with Lima Corporate for an expanded partnership for the United States implant market.

The two companies initiated their collaboration in 2009 with a limited distribution agreement that leveraged each company's product portfolios and increased their separate product offerings to better serve their respective customers. DJO Surgical launched the first of Lima's products in the U.S., a revision hip system, late in the third quarter of 2010, with strong early sales momentum. Lima is successfully distributing DJO Surgical's 3D Knee and Foundation Total Knee system in selected European markets. The new strategic partnership provides for an expanded range of DJO and Lima Corporate products to be jointly marketed in the U.S., offering customers quicker access to a comprehensive product portfolio in joint replacement, extremities and fracture repair. To support the new distribution partnership, a new legal entity, DJO Lima Orthopedics, LLC will be formed. The new agreement is expected to become effective by April 2011.

"We are very pleased to expand our relationship with Lima Corporate," said Les Cross, president and chief executive officer of DJO Global. "Like DJO, Lima is an innovative company and the combination of our product portfolios will provide a state-of-the-art and comprehensive offering to better serve our customers and meet the needs of today's complex procedures."

In commenting on the new agreement, Stefano Alfonsi, chief executive officer for Lima Corporate said, "Lima Corporate has grown at a compounded annual growth rate of over 28% for the last two years in European and Asia-Pacific markets, reaching a leading position in shoulder and hip segments, driven by innovative orthopedic solutions and an aggressive geographic expansion. We are committed to continue our growth by offering Lima's solutions to the sophisticated and demanding U.S. surgeons, and we are eager to embrace U.S. surgeons' ideas and convert those ideas into exciting products. The partnership with DJO will enable us to efficiently access this market, and together with the well regarded DJO organization, to provide a high level of service to customers."

In a separate release today, DJO announced that its name has been changed from DJO Incorporated to DJO Global, Inc.

About DJO Global

DJO Global is a leading global developer, manufacturer and distributor of high-quality medical devices that provide solutions for musculoskeletal health, vascular health and pain management. The Company's products address the continuum of patient care from injury prevention to rehabilitation after surgery, injury or from degenerative disease, and are used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers and other healthcare professionals. In addition, many of the Company's medical devices and related accessories are used by athletes and patients for injury prevention and at-home physical therapy treatment. The Company's product lines include rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular systems, electrical stimulators used for pain management and physical therapy products. The Company's surgical division offers a comprehensive suite of reconstructive joint products for the hip, knee and shoulder. DJO's products are marketed under the brands Aircast®, DonJoy®, ProCare®, CMF™, Empi®, Saunders®, Chattanooga, DJO Surgical, Compex®, Cefar®-Compex® and Ormed®. DJO uses its website as a channel of distribution of material Company information. Financial and other material information regarding the Company is routinely posted and accessible at www.DJOglobal.com.

About Lima Corporate

Lima Corporate is a privately owned European company. Lima Corporate achieved over $130 million in sales in 2010 through its 14 owned sales and marketing organizations across most European countries and Asia-Pacific, in particular Japan, Australia and New Zealand, acting as a global player but keeping the closeness of a local company.

Lima Corporate Vision: Restoring the Emotion of Motion

Lima Corporate Mission: Lima Corporate intends to continue to significantly outgrow the orthopaedic market. One example of Lima Corporate's ability to evolve orthopedics is the Trabecular Titanium™: the use of an innovative technology to produce a structure that imitates the bone, applied to an acetabular cup system, provides excellent and long term bone integration thanks to the dimension and the morphology of the trabecular structure. The concept "patients needs at the centre" has driven the development of the Multigen Plus Biolox® Delta Ceramic Knee, the first and unique European femoral component made of ceramic that ensures a reduced wear and a metal-free solution for allergic patients. The SMR system, market leader in shoulder replacement in several European and Asia-Pacific countries, thanks to its modularity, offers a "custom made like" solution to the surgeons for the treatment of all shoulder pathologies. The use of polymers for fracture repair products is also a Lima Corporate achievement; the DiPhos plating system offers solutions for upper limb extremities: DiPhos H for proximal humeral fractures and DiPhos R for distal radius fractures. Translucency of this material and polyaxial self-tapping angular stable screws allow secure intraoperative reconstruction and an effective evaluation of fracture healing.For additional information on Lima Corporate, please visit www.lima.it.

DJO Investor/Media Contact:
DJO Global, Inc.
Mark Francois, Director of Investor Relations
(760) 734-4766
Email: mark.francois[at]djoglobal[dot]com
Lima Media Contact:
Lima Corporate
Alessia Zuliani, Investors Relations
+39 0432 94 56 77
Email: azu[at]lima[dot]it